INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test
At DNA Labs UAE, we offer the INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test to help diagnose respiratory illnesses during flu seasons. This diagnostic test is used to detect both influenza viruses and the SARS-CoV-2 virus (which causes COVID-19) in individuals who exhibit symptoms similar to influenza.
Test Components
- Sars-CoV-2 (Covid-19) RT-PCR
- H1N1 RT-PCR
- H3N2 & Influenza B RT-PCR
Price
The cost of the INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test is 2000.0 AED.
Sample Condition
To perform the test, please submit Nasopharyngeal and Oropharyngeal Swabs inoculated in special viral transport medium (VTM) available from LPL. These samples should be shipped refrigerated in a special transport box available from LPL. Additionally, please ensure to fill the Swine Flu / H1N1 Clinical Information Form (Form 25) and Covid-19 Clinical Information Form (Form 44) or provide the SRF ID as mandated by GOI.
Report Delivery
The test reports are delivered daily by 11 am for samples submitted, with the exception of Sundays. The report is typically available within 2 days.
Method
The INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test is performed using Real Time RT-PCR method.
Test Type
This test is used to detect infections.
Doctor
The test can be ordered by a physician.
Test Department
The test is conducted in the Test Department of DNA Labs UAE.
Pre Test Information
It is mandatory to fill the Swine Flu / H1N1 Clinical Information Form (Form 25) and Covid-19 Clinical Information Form (Form 44) or provide the SRF ID as mandated by GOI before undergoing the test.
Test Details
The INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test is designed to simultaneously detect and differentiate between the influenza A virus, influenza B virus, and the SARS-CoV-2 virus using molecular techniques like PCR (Polymerase Chain Reaction) or RT-PCR (Reverse Transcription Polymerase Chain Reaction). By testing for both influenza viruses and SARS-CoV-2 at the same time, healthcare providers can quickly identify the cause of the illness and take appropriate actions such as initiating isolation or quarantine protocols, providing appropriate treatment, or recommending further testing. The test is typically performed using respiratory samples, such as nasal or throat swabs, which are collected from the patient. These samples are then processed in a laboratory, where the genetic material of the viruses is extracted and amplified for detection. It is important to note that this test is not a substitute for specific testing for COVID-19 alone. If someone is suspected to have COVID-19 but tests negative for influenza, further testing for SARS-CoV-2 may still be necessary. The INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test plays a crucial role in diagnosing respiratory illnesses during flu seasons, especially when there is a need to differentiate between influenza and COVID-19, as the symptoms of these illnesses can overlap.
Test Name | INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test |
---|---|
Components | *Sars-CoV-2 (Covid-19) RT-PCR *H1N1 RT-PCR *H3N2 & Influenza B RT-PCR |
Price | 2000.0 AED |
Sample Condition | Submit Nasopharyngeal and Oropharyngeal Swabs inoculated in special viral transport medium (VTM) available from LPL. Ship refrigerated in a special transport box available from LPL. Duly filled Swine Flu \/ H1N1 Clinical Information Form (Form 25) and Covid-19 Clinical Information Form (Form 44) \/ SRF ID as mandated by GOI is mandatory. |
Report Delivery | Sample Daily by 11 am: Report 2 days (Except Sundays) |
Method | Real Time RT-PCR |
Test type | Infections |
Doctor | Physician |
Test Department: | |
Pre Test Information | Duly filled Swine Flu / H1N1 Clinical Information Form (Form 25) and Covid-19 Clinical Information Form (Form 44) / SRF ID as mandated by GOI is mandatory. |
Test Details |
The Influenza-Like Illness (ILI) SARS-CoV-2 Panel test is a diagnostic test used to detect both influenza viruses and the SARS-CoV-2 virus (which causes COVID-19) in individuals who exhibit symptoms similar to influenza. This panel test is designed to simultaneously detect and differentiate between the influenza A virus, influenza B virus, and the SARS-CoV-2 virus using molecular techniques like PCR (Polymerase Chain Reaction) or RT-PCR (Reverse Transcription Polymerase Chain Reaction). By testing for both influenza viruses and SARS-CoV-2 at the same time, healthcare providers can quickly identify the cause of the illness and take appropriate actions such as initiating isolation or quarantine protocols, providing appropriate treatment, or recommending further testing. The ILI SARS-CoV-2 Panel test is typically performed using respiratory samples, such as nasal or throat swabs, which are collected from the patient. These samples are then processed in a laboratory, where the genetic material of the viruses is extracted and amplified for detection. It is important to note that this test is not a substitute for specific testing for COVID-19 alone. If someone is suspected to have COVID-19 but tests negative for influenza, further testing for SARS-CoV-2 may still be necessary. The ILI SARS-CoV-2 Panel test plays a crucial role in diagnosing respiratory illnesses during flu seasons, especially when there is a need to differentiate between influenza and COVID-19, as the symptoms of these illnesses can overlap. |